ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2016 ACR/ARHP Annual Meeting

November 11-16, 2016 in Washington, DC

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z
  • Abstract Number: 475
    N-3 Polyunsaturated Fatty Acids in Fat-1 Mice Attenuate Collagen Antibody-Induced Arthritis
  • Abstract Number: 2582
    N-Acetylcysteine Regulates Osteoclastogenesis and Th17 Cell Differentiation in Rheumatoid Arthritis
  • Abstract Number: 2917
    Nailfold Capillaroscopy and Mortality in Systemic Sclerosis
  • Abstract Number: 2165
    Natural Language Processing to Rapidly Identify Potential Signals for Adverse Events Using Electronic Medical Record Data: Example of Arthralgias and Vedolizumab
  • Abstract Number: 2848
    Near Patient Anti-Nuclear Antibody Multiplex Testing Using Whole Blood for the Diagnosis of Connective Tissue Diseases in a Tertiary Care Center
  • Abstract Number: 922
    Negative Regulation of IL-17 Receptor Signaling By Regnase-1 Limits Immunopathology in a Mouse Model of Psoriatic Skin Disease
  • Abstract Number: 1047
    Negative Results of Antinuclear Antibody (ANA) Testing in Clinical Trials of Systemic Lupus Erythematosus (SLE) May be Due to Assay Variability
  • Abstract Number: 2265
    NET-Inducing Capacity Is a Biomarker in ANCA-Associated Vasculitis Independent of ANCA Antibodies
  • Abstract Number: 589
    Netosis-Derived Products Might Have Diagnostic Potential for Disease Activity, Atherosclerosis and Analysis of Therapeutic Effectiveness in Rheumatoid Arthritis Patients
  • Abstract Number: 1437
    Netrin-1 and Its Receptor Unc5b Are Novel Targets for the Treatment of Inflammatory Arthritis
  • Abstract Number: 1627
    Network Meta-Analysis to Assess the Relative Efficacy of Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, in Combination Therapy for Patients with Active Rheumatoid Arthritis Despite Conventional Dmards
  • Abstract Number: 1348
    Neuromyelitis Optica: Patient Characteristics and Treatment Patterns Among Rheumatologists Versus Non-Rheumatologists
  • Abstract Number: 3102
    Neutrophil Subsets, Arterial Inflammation, and Vascular Stiffness in Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2853
    Neutrophilia in Systemic Lupus Erythematosus As a Potential Indicator of Disease Activity
  • Abstract Number: 233
    New Cardiovascular Risk Factors Screening in Patients with Gout
  • Abstract Number: 872
    New Insights into the Pathogenesis of Giant Cell Arteritis through a Genome-Wide Association Study
  • Abstract Number: 1359
    New Markers for Celiac Disease: Anti-Neo-Epitope Human and Microbial Transglutaminases
  • Abstract Number: 2763
    New Treatment Option for SAPHO?
  • Abstract Number: 2415
    Next Generation Sequencing Analysis of Familial Haemophagocytic Lymphohistiocytosis (HLH) Related Genes in Macrophage Activation Syndrome (MAS) and Secondary HLH (secHLH)
  • Abstract Number: 2868
    NK Cell Characterization in Patients with Systemic Lupus Erythematosus: Increased Frequency of Ki67+ NK Cells Associated with Disease Activity and Type I Interferon Signature
  • Abstract Number: 254
    NLRP12 Autoinflammatory Disease: A Chinese Case Series and Literature Review
  • Abstract Number: 2075
    No Detection of Varicella-Zoster Virus in Temporal Arteries of Patients with Giant Cell Arteritis
  • Abstract Number: 1864
    No Evidence of Association of ATP8B4 F436L missense Variant in a Large Systemic Sclerosis Cohort
  • Abstract Number: 1957
    No Increased Risk of Chronic Kidney Disease with Allopurinol Use
  • Abstract Number: 962
    No Increased Risk of Inflammatory Bowel Disease Among Secukinumab-Treated Patients with Moderate to Severe Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis: Data from 14 Phase 2 and Phase 3 Clinical Studies
  • Abstract Number: 2636
    No Strong Evidence Supporting Predictors for Successful Dose Reduction or Discontinuation of a Biologic in Rheumatoid Arthritis: A Systematic Review
  • Abstract Number: 2098
    Non-­Criteria Anti­-Phospholipid Antibodies in SLE Patients
  • Abstract Number: 3073
    Non-Additive Interaction of the Glucokinase Regulatory Protein and APOBEC1 Complementation Factor Loci with Alcohol Consumption to Influence the Risk of Gout
  • Abstract Number: 2830
    Non-Calcified Coronary Artery Plaque Associates with Adverse Lipoprotein Profiles in Systemic Lupus Erythematosus
  • Abstract Number: 1062
    Non-Conventional Antiphospholipid Antibodies in Patients with Clinical Obstetrical APS: Prevalence and Pregnancies Treatment Efficacy
  • Abstract Number: 1115
    Non-Esterified Fatty Acids Are Associated with Clinical Features and an Enhanced Th1 Response in Rheumatoid Arthritis: Towards Disease Profiling
  • Abstract Number: 1863
    Non-Invasive Investigation of Perfusion, Microvascular Structure, Erythema, Oxidative Stress and Oxygenation in Healthy Controls and in Patients with Primary and Secondary Raynaud’s Phenomenon
  • Abstract Number: 1997
    Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis – Impact on s-Infliximab and Antidrug-Antibodies. Results from the Danish Rheumatologic Biobank and the Danbio Registry
  • Abstract Number: 483
    Non-Steroidal Anti-Inflammatory Drugs Are More Beneficial Than Anti-Tnfα Drugs on the Radiographic Damage in Arthritis: A Study in Adjuvant Induced Arthritis
  • Abstract Number: 1087
    Nonmemory B Cell Signature Alterations in Belimumab Patients
  • Abstract Number: 2877
    Notch Ligand Delta-like Ligand 4 (DLL4) Expression on Dendritic Cells Is Increased in Systemic Lupus Erythematosus
  • Abstract Number: 59
    Novel Agents for Blocking the Interaction of Immune Complexes with the Activatory FcγRIIIa Receptor
  • Abstract Number: 2984
    Novel Anti-Malarial Drug Derivative Inhibited Type I Interferon Production and Autoimmune Inflammation through Inhibition of CGAS-Sting Pathway in Trex1-/- Mouse
  • Abstract Number: 2424
    Novel Autoantigens for Anti- Endothelial Cell Antibodies in Pediatric Rheumatic Diseases Identified By Proteomics
  • Abstract Number: 46
    Novel Composite Responder Endpoints for Fibromyalgia Therapy Assessment
  • Abstract Number: 1391
    Novel Electronic Health Record-Based Method Confirms Increased Renal Disease Burden in Pediatric-Onset Vs. Adult-Onset Patients with Systemic Lupus Erythematosus
  • Abstract Number: 2832
    Novel Gene Variants Associated with Cardiovascular Disease in Systemic Lupus Erythematosus
  • Abstract Number: 2789
    Novel Glucocorticoid Prodrug Effectively Attenuates Late Stage Lupus Nephritis with Improved Safety Profile
  • Abstract Number: 916
    Novel Immunosignature Stratifies Patients with Rheumatoid Arthritis into Distinct Disease Sub-Groups and Predicts Response to Anti-Tnfα Therapies
  • Abstract Number: 457
    Novel Mechanism Mediated By the IL-23/Th17 Axis Contributing to Auto-Immune Arthritis
  • Abstract Number: 2154
    Novel Pathogenic Functions of IL-11 on RA Joint Fibroblasts and Endothelial Cells
  • Abstract Number: 1756
    Novel Role of Rho Kinase in Neutrophil Netosis during UVB Induced-Skin Inflammation
  • Abstract Number: 2034
    Novel Susceptible Genes for Behçet’s Disease Identified By Dense Genotyping of Immune-Related Loci Implicate Host Responses to Microbial Exposure
  • Abstract Number: 717
    NSAID Use and Functional Impairment in Ankylosing Spondylitis
  • Abstract Number: 434
    Nurse Scheduled Telephone Visit: The Right Rheumatology Care for the Right Patient at the Right Time
  • Abstract Number: 189
    Nutraceutical Therapy with Polyphenol-Rich Pomegranate Fruit Extract (POMx) Inhibits Systemic NFκB-Mediated Inflammation in a Murine Model of Endotoxemia
Jump to:  View All • a b c d e f g h i j k l m [n] o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Chicago, IL

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.